[HTML][HTML] Ivermectin as a potential drug for treatment of COVID-19: an in-sync review with clinical and computational attributes
H Kaur, N Shekhar, S Sharma, P Sarma… - Pharmacological …, 2021 - Springer
Introduction COVID-19 cases are on surge; however, there is no efficient treatment or vaccine
that can be used for its management. Numerous clinical trials are being reviewed for use …
that can be used for its management. Numerous clinical trials are being reviewed for use …
Promising traditional Indian medicinal plants for the management of novel Coronavirus disease: A systematic review
…, H Kaur, G Batra, P Sarma, H Kaur… - Phytotherapy …, 2021 - Wiley Online Library
Traditional Indian medical practices (Ayurveda, Siddha, Unani, and homeopathy) are a vast
reservoir of knowledge about medicinal plants. The promising pharmacological properties of …
reservoir of knowledge about medicinal plants. The promising pharmacological properties of …
[HTML][HTML] COVID-19 pandemic: A review based on current evidence
…, D Mahendru, A Semwal, S Kaur, H Kaur… - Indian journal of …, 2020 - journals.lww.com
In December 2019, severe acute respiratory syndrome-coronavirus-2, a novel coronavirus,
initiated an outbreak of pneumonia from Wuhan in China, which rapidly spread worldwide. …
initiated an outbreak of pneumonia from Wuhan in China, which rapidly spread worldwide. …
Clinically relevant cell culture models and their significance in isolation, pathogenesis, vaccine development, repurposing and screening of new drugs for SARS-CoV …
S Kumar, P Sarma, H Kaur, M Prajapat… - Tissue and Cell, 2021 - Elsevier
Background In-Vitro/Cellular evidence is the backbone and vital proof of concept during the
development of novel therapeutics as well as drugs repurposing against COVID-19. …
development of novel therapeutics as well as drugs repurposing against COVID-19. …
Ocular manifestations and tear or conjunctival swab PCR positivity for 2019-nCoV in patients with COVID-19: a systematic review and meta-analysis
P Sarma, H Kaur, H Kaur, J Bhattacharyya… - Available at SSRN …, 2020 - papers.ssrn.com
Background: Ocular tropism of respiratory viruses is a known fact. Many of the patients with
COVID-19 also have concomitant ocular symptoms and in some of them, ocular symptoms …
COVID-19 also have concomitant ocular symptoms and in some of them, ocular symptoms …
Futuristic approach to cancer treatment
D Malik, S Mahendiratta, H Kaur, B Medhi - Gene, 2021 - Elsevier
Cancer is becoming one of the deadliest disease in both developed as well as developing
countries and continuous effort is being made to find innovative therapies for myriad types of …
countries and continuous effort is being made to find innovative therapies for myriad types of …
Pharmacological modulation of TRPM2 channels via PARP pathway leads to neuroprotection in MPTP-induced Parkinson's disease in Sprague dawley rats
Transient receptor potential melastatin-2 (TRPM2) channels are cation channels activated by
oxidative stress and ADP-ribose (ADPR). Role of TRPM2 channels has been postulated in …
oxidative stress and ADP-ribose (ADPR). Role of TRPM2 channels has been postulated in …
Indomethacin: an exploratory study of antiviral mechanism and host-pathogen interaction in COVID-19
N Shekhar, H Kaur, P Sarma, A Prakash… - Expert review of anti …, 2022 - Taylor & Francis
Introduction COVID-19, a dreadful pandemic that has impacted human life like no other
pathogenic invasion, has claimed the lives of over 100 million people. The need for effective …
pathogenic invasion, has claimed the lives of over 100 million people. The need for effective …
Behavior of uptake of moisture by drugs and excipients under accelerated conditions of temperature and humidity in the absence and the presence of light. 1. Pure …
An investigation was carried out to determine the behavior of moisture gain by four anti-tuberculosis
drugs, viz. rifampicin, isoniazid, pyrazinamide and ethambutol, when exposed in …
drugs, viz. rifampicin, isoniazid, pyrazinamide and ethambutol, when exposed in …
Premature graying of hair: Risk factors, co‐morbid conditions, pharmacotherapy and reversal—A systematic review and meta‐analysis
…, P Sarma, H Kaur, S Kaur, H Kaur… - Dermatologic …, 2020 - Wiley Online Library
Premature graying of hair (PGH) being a very common entity for which pharmacotherapy and
reversibility are not properly addressed. Therefore, this systematic review was conducted …
reversibility are not properly addressed. Therefore, this systematic review was conducted …